Patients with Schinzel-Giedion Syndrome have seen significant improvement following treatment with marijuana
Schinzel-Giedion syndrome is a rare but debilitating disease. It leads to kidney malfunction, a displacement of intestines and a lack of nerve fibers that link the two hemispheres in the brain. More often than not, it leade to an early an untimely death and standard treatments – opioids, steroids, surgeries – have not produced any positive results. However, it would now appear that cannabidiol (CBD) oil is working wonders.
At only nine months, Sadie Higuera was suffering from Schinzel-Giedion when, after spending tens of thousands of dollars on ineffective treatment, doctors suggested to her parents that they let her pass. One doctor told them, “It’s time for you to be your daughter’s hero and discontinue her medications.”
Sadie’s parents ignored the advice and began a treatment program that included CBD. Now, five years later, Saide is alive and seizure-free. CBDs, thanks to cases like Sadie’s, are prescribed more and more to battle a number of ailments, especially in children due to the absence of psychoactive properties in the drug.
Legal use of marijuana in the US has been blocked for over 40 years. This has prevented studies on the drug’s properties, causing millions of people to needlessly suffer. Now that states are backtracking on their view of cannabis and marijuana, research is expanding and there are surprising new developments made every day.
CBDs have already been shown to be effective for a variety of ailments, including heart disease, Parkinson’s disease, arthritis and Alzheimer’s. They have also been shown in limited studies to help conquer epilepsy. Due to federal regulations, the marijuana industry is 40 years behind in innovating and exploring the benefits of marijuana, but at least progress is finally being made.
